Integrative human atrial modeling unravels interactive PKA and CaMKII signaling as key determinant of atrial arrhythmogenesis.
Haibo NiStefano MorottiXianwei ZhangDobromir DobrevEleonora GrandiPublished in: Cardiovascular research (2023)
Atrial fibrillation (AF), the most prevalent clinical arrhythmia, is associated with atrial remodeling manifesting as acute and chronic alterations in expression, function, and regulation of atrial electrophysiological and Ca2+-handling processes. These AF-induced modifications crosstalk and propagate across spatial scales creating a complex pathophysiological network, which renders AF resistant to existing pharmacotherapies that predominantly target transmembrane ion channels. Developing innovative therapeutic strategies requires a systems approach to disentangle quantitatively the proarrhythmic contributions of individual AF-induced alterations. Here, we built a novel computational framework for simulating electrophysiology and Ca2+-handling in human atrial cardiomyocytes and tissues, and their regulation by key upstream signaling pathways (i.e., protein kinase A, PKA, and Ca2+/calmodulin-dependent protein kinase II, CaMKII) involved in AF-pathogenesis. Populations of atrial cardiomyocyte models were constructed to determine the influence of subcellular ionic processes, signaling components, and regulatory networks on atrial arrhythmogenesis. Our results reveal a novel synergistic crosstalk between PKA and CaMKII that promotes atrial cardiomyocyte electrical instability and arrhythmogenic triggered activity. Simulations of heterogeneous tissue demonstrate that this cellular triggered activity is further amplified by CaMKII- and PKA-dependent alterations of tissue properties, further exacerbating atrial arrhythmogenesis. Our analysis reveals potential mechanisms by which the stress-associated adaptive changes turn into maladaptive proarrhythmic triggers at the cellular and tissue levels and identifies potential anti-AF targets. Collectively, our integrative approach is powerful and instrumental to assemble and reconcile existing knowledge into a systems network for identifying novel anti-AF targets and innovative approaches moving beyond the traditional ion channel-based strategy.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- protein kinase
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- heart failure
- high glucose
- endothelial cells
- percutaneous coronary intervention
- angiotensin ii
- genome wide
- gene expression
- long non coding rna
- poor prognosis
- drug induced
- oxidative stress
- epithelial mesenchymal transition
- induced pluripotent stem cells
- acute coronary syndrome
- diabetic rats
- extracorporeal membrane oxygenation
- drug delivery
- risk assessment
- mitral valve
- fluorescent probe
- climate change
- acute respiratory distress syndrome